Clinical Research Directory
Browse clinical research sites, groups, and studies.
Development of a Quantifiable Ultrasound Biomarker for Hepatic Steatosis
Sponsor: ContextVision AB
Summary
The research study is considering a non-invasive way to measure the percentage of fat in the liver using ultrasound. This could help detect early signs of a very common condition called metabolic dysfunction-associated steatotic liver disease (MASLD). Current tests, like MRI or biopsy, can be expensive or invasive. If successful, this ultrasound tool could become an easier and more accessible way to monitor liver health - especially for people with obesity, diabetes, high blood pressure, or high cholesterol.
Official title: Development and Diagnostic Evaluation of a Novel Quantifiable Ultrasound Based Multi-parametric Biomarker for Hepatic Steatosis in Patients With Suspected MASLD ( LYNX )
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
110
Start Date
2025-11-17
Completion Date
2026-12-31
Last Updated
2025-12-08
Healthy Volunteers
Yes
Conditions
Interventions
Verasonics NXT Data Acquisition System
A research ultrasound imaging device to capture raw radiofrequency ultrasound data for the following parameters: * B-mode imaging * Attenuation coefficient * Backscatter coefficient * Speed of sound * Shear wave elastography
Philips EPIQ Elite
A premium ultrasound system with software package to support imaging research studies.
EchoSense FibroScan
A non-invasive ultrasound solution that accurately measures liver stiffness and liver steatosis.
Philips 3T Ingenia Elition
A 3-tesla magnetic resonance imaging (MRI) system
Locations (1)
University of Washington
Seattle, Washington, United States